1,610.50
-6.00
(-0.37%)
As of 1:21:47 PM GMT+9. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
110,660,000.00
110,660,000.00
159,610,000.00
61,829,000.00
73,977,000.00
Investing Cash Flow
48,077,000.00
48,077,000.00
-100,259,000.00
6,038,000.00
-57,586,000.00
Financing Cash Flow
-89,848,000.00
-89,848,000.00
-32,484,000.00
-60,237,000.00
-24,754,000.00
End Cash Position
166,141,000.00
166,141,000.00
96,135,000.00
69,112,000.00
61,045,000.00
Capital Expenditure
-20,829,000.00
-20,829,000.00
-14,497,000.00
-12,277,000.00
-20,293,000.00
Repurchase of Capital Stock
-50,010,000.00
-50,010,000.00
-1,000.00
-30,007,000.00
-3,000.00
Free Cash Flow
89,831,000.00
89,831,000.00
145,113,000.00
49,552,000.00
53,684,000.00
3/31/2021 - 1/4/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4503.T Astellas Pharma Inc.
1,516.00
-0.85%
LLY.DU Eli Lilly and Co
786.70
+2.29%
4519.T Chugai Pharmaceutical Co., Ltd.
6,724.00
+5.62%
RHHVF Roche Holding AG
318.00
+1.89%
1093.HK CSPC PHARMA
4.460
-0.67%
BAYN.DE Bayer Aktiengesellschaft
21.86
+1.49%
GSK.L GSK plc
1,402.00
+0.11%
BIIB Biogen Inc.
146.23
+1.26%
GILD Gilead Sciences, Inc.
96.95
+1.42%
GSK GSK plc
35.36
+0.86%